Journal of Clinical & Experimental OncologyISSN: 2324-9110

Reach Us +1 850 900 2634
All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.

Research Article, J Clin Exp Oncol Vol: 5 Issue: 6

VEGF Expression Evaluation in Patients with Esophageal Cancer by using Reverse Transcriptase Real- Time Polymerase Chain Reaction

Hadiseh Farzanfar1, Gholamreza Motalleb1* and Hossein Maghsoudi2
1Department of Biology, Faculty of Sciences, University of Zabol, Zabol, Islamic Republic of Iran
2Department of Biology, Payam Noor University (PNU), Tehran, Islamic Republic of Iran
Corresponding author : Dr. Gholamreza Motalleb
Associate Professor, Department of Biology, Faculty of Science, University of Zabol, P.O. Box 98615-53, Iran
E-mail: [email protected], [email protected]
Received: May 26, 2016 Accepted: November 22, 2016 Published: November 30, 2016
Citation: Farzanfar H, Motalleb G, Maghsoudi H (2016) VEGF Expression Evaluation in Patients with Esophageal Cancer by using Reverse Transcriptase Real- Time Polymerase Chain Reaction. J Clin Exp Oncol 5:6. doi: 10.4172/2324-9110.1000167

Abstract

Objective: Esophageal cancer is the 8th most important cancer in the world which is responsible for about 1.5 million cases and 1 million morbidity rates per year. One of the most specific regulators of neovascularization is VEGF. VEGF genes are mutated in the different type of esophageal cancers which leads to neovascularization process and tumor metastasis. In this qualitative research work, for the first time, we investigated the VEGF gene expression in esophageal cancer patients in IRAN.

Methods: This study was performed on 30 FFPE (formalin fixed paraffin embedded) (15 specimens were healthy and 15 specimens) were esophageal cancer tissues which were gathered from different hospitals and research centers in Zahedan and Kashan in Iran. We aimed to evaluate the expression of VEGF genes using reverse transcriptase real-time polymerase chain reaction method. PCR reactions for VEGF gene as well as internal control (β-actin) was performed 3 times using 2 -ΔΔCT (Livac) method for all specimens. Then the difference in gene expressions between case and control groups evaluated using the t-test, in which p ≤ 0.05 was considered to be significant.

Results: There was a meaningful increase in VEGF gene expression in the case group. There was not a meaningful difference in gene expression in male or female in case or control groups (P>0.05).

Conclusion: The results showed that VEGF gene expression in patients was increased compared to control.

Keywords: Esophageal cancer; VEGF; Reverse transcriptase real- time polymerase chain reaction

Track Your Manuscript

Share This Page

Media Partners